Boston, MA -- (SBWIRE) -- 06/04/2014 -- Weight management in Ireland increased in current value by 2% in 2013, with growth compromised by the poor performance of OTC obesity due to the withdrawal of GlaxoSmithKline (Ireland) Ltd's product Alli. Alli and OTC obesity in general suffered significantly in 2012 as a result of the brand's supply problems, which lasted for the majority of the year and led to OTC obesity declining in current value by 72% in 2012. 2013 saw little respite, with value sales of OTC obesity falling by a further 10% as a significant number of chemists/pharmacies failed to restock the product, citing the lack of interest in the product as the main reason. In a difficult trading environment where credit is limited and stock levels are being kept to the absolute minimum, it is unsurprising that so many chemist/pharmacies were unwilling to stock a product for which there is now very limited demand in Ireland.

View Full Report Details and Table of Contents

Competitive Landscape

Unilever Ireland Ltd remained the leading player in weight management in Ireland in 2013 with a 44% value share through its Slim Fast range of weight loss products. Although the brand has received little support in terms of advertising and marketing in recent years, it remains an iconic weight loss brand. The Slim Fast website offers consumers the opportunity to track their weight loss progress and communicate with other users of the products, which allows them to provide and receive support and encouragement. There are other product ranges such as Celebrity Slim which aim to offer similar programmes, although none of these has yet achieved the success or longevity of the Slim Fast brand.

Industry Prospects

Weight management is expected to increase in value at a CAGR of 2% in constant 2013 terms over the forecast period. Growth in the category is set to be compromised by the fallout from the weak performance of OTC obesity towards the end of the review period as the decline and withdrawal of the Alli brand continues to have a substantial impact on the category overall. Weight loss supplements, meanwhile, is expected to increase in value at a CAGR of 3% in constant 2013 terms over the forecast period as interest in dietary supplements continues to increase, with sustained new product development and diversification driving consumer interest and growth in the category.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Slimming Products industry in Ireland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

- North America Weight Loss/Obesity Management Market - [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, Gastric Bypass, Intragastric Balloon System, StomaphyX] - Forecasts to 2017
- Weight Loss/Obesity Management Market - Global Forecasts To 2017
- Weight Management in Pakistan
- Weight Management in South Korea
- Weight Management in Macedonia
- Weight Management in Guatemala
- Weight Management in India
- Weight Management in Canada
- Weight Management in China
- Weight Management in Bulgaria